Howard Rutman, M.D.

Howard joined Xalud Therapeutics with decades of relevant industry and healthcare experience. Howard has also worked at Pfizer as the senior director and global medical affairs lead for multiple monoclonal antibody biosimilars under development in oncology and immunology. Before his roles in the industry, Howard practiced cardiology in a New York-based academic, private practice, with a focus on managing patients with chronic congestive heart failure. He received his M.D. from Johns Hopkins University School of Medicine.